| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S82533-1mg买3赠1 |
99.90% | ￥100.00 |
9 | - | - | - | - |
|
S82533-2mg买3赠1 |
99.90% | ￥150.00 |
9 | - | - | - | - |
|
S82533-5mg买3赠1 |
99.90% | ￥290.00 |
9 | - | - | - | - |
|
S82533-10mg买3赠1 |
99.90% | ￥520.00 |
6 | - | - | - | - |
|
S82533-50mg买3赠1 |
99.90% | ￥1930.00 |
6 | - | - | - | - |
|
| 产品描述： | QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively). IC50 value: 3 μM (for NR2D), 6 μM (for NR2C), 229 μM (for NR2D NR2A) Target: NR2D, NR2C, NR2A in vitro: QNZ46 is a noncompetitive inhibitor of GluN2C/D containing NMDA receptors. KD and IC50 values for binding and inhibition of GluN1/Glun2D receptors by QNZ46 are 4.9 and 3.9 μM, respectively. QNZ46 does not compete for binding of glutamate or glycine, but QNZ46 receptor binding requires the binding of glutamate to the GluN2 subunit. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | iGluR;NMDAR; iGluR | ||||||||||||||||||||
| 参考文献： | 1. Hansen KB, et al. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci. 2011 Mar 9;31(10):3650-3661. | ||||||||||||||||||||
| 溶解性： | DMSO : ≥ 4.5 mg/mL (10.15 mM) | ||||||||||||||||||||
| 保存条件： | RT | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京